+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes



Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes



Diagnostic Molecular Pathology 10(4): 228-235



Chondrosarcomas are malignant cartilaginous tumors. Most are located in the medullar cavity (central chondrosarcoma), and a minority develop in a preexisting osteochondroma (peripheral chondrosarcoma). The authors present karyotypes for 37 central, peripheral, juxtacortical, and dedifferentiated chondrosarcomas. Using loss of heterozygosity (LOH) analysis and DNA flow cytometry, the authors previously showed that central and peripheral chondrosarcomas probably evolve by different genetic mechanisms. Peripheral chondrosarcoma is characterized by genetic instability, as was previously shown by a high percentage of LOH and a broad range in DNA ploidy. The authors now show that all peripheral chondrosarcomas tested are aneuploid, combined with many nonspecific chromosomal aberrations. Two juxtacortical chondrosarcomas showed normal chromosome numbers combined with limited structural alterations, substantiating that juxtacortical and peripheral chondrosarcomas are two clinicopathologically different entities with a different genetic background. Central chondrosarcomas were previously found to be peridiploid with limited LOH, most frequent at 9p21. In the current study, chromosome 9 was involved in five of seven central chondrosarcomas compared with only one of four peripheral chondrosarcomas. Three central tumors showed involvement of the 9pl2-22 region, suggesting an important role for chromosome 9 in the oncogenesis of central chondrosarcoma. Moreover, trisomy 22 was found in four central chondrosarcomas only.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 045513873

Download citation: RISBibTeXText

PMID: 11763313


Related references

Cytogenetic and flow cytometric analysis of a clear cell chondrosarcoma. Cancer Genetics & Cytogenetics 52(2): 193-200, 1991

DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma. Scandinavian Journal of Thoracic and Cardiovascular Surgery 30(3-4): 157-161, 1996

Mesenchymal chondrosarcoma: a clinicopathologic and flow cytometric study of 13 cases presenting in the central nervous system. Cancer 77(9): 1884-1891, 1996

Comparative DNA cytometric and cytogenetic ploidy determination of chondrosarcoma and osteosarcoma. Der Pathologe 17(5): 374-379, 1996

Trisomy 8 as the sole cytogenetic abnormality in a case of extraskeletal mesenchymal chondrosarcoma. Cancer Genetics and Cytogenetics 159(2): 151-154, 2005

Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone. Bmc Cancer 12: 375, 2013

Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 80(12): 1925-1934, 2001

Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Laboratory Investigation 80(12): 1925-1933, 2000

A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma. Cancer 66(6): 1176-1182, 1990

Chondrosarcoma of bone. A clinical and DNA flow cytometric study. European Journal of Surgical Oncology 21(4): 408-413, 1995

Cytogenetic, molecular cytogenetic, and mutational analysis of 8q241 in 47 osteochondroma and chondrosarcoma specimens. American Journal of Human Genetics 65(4): A119, 1999

Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype. Histopathology 67(4): 483-490, 2016

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma. Bmc Cancer 16: 479, 2017

Cytogenetic analysis in chondrosarcoma. Journal of Cancer Research and Clinical Oncology 121(1 Suppl.): A36-0, 1995

Chondrosarcoma. II. Chondrosarcoma of the jaws: analysis of 37 cases. Journal of Oral Pathology 17(1): 12-20, 1988